MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

03 Oct 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg. The company has enclosed a press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..